Immune checkpoint inhibitors in ovarian cancer: where do we stand?
10.1177/17588359211039899
Saved in:
Main Authors: | Leary, A, Tan, D, Ledermann, J |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
SAGE Publications
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206503 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
by: Ng K.Y.Y., et al.
Published: (2022) -
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
by: Wang, Dongdong, et al.
Published: (2023) -
Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer
by: Goggi, Julian L., et al.
Published: (2022) -
Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
by: Sundar, R., et al.
Published: (2021) -
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLC
by: Huang, Y, et al.
Published: (2023)